Compare COO & DKNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COO | DKNG |
|---|---|---|
| Founded | 1980 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 12.4B |
| IPO Year | 1994 | 2021 |
| Metric | COO | DKNG |
|---|---|---|
| Price | $71.05 | $25.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 31 |
| Target Price | ★ $90.18 | $38.10 |
| AVG Volume (30 Days) | 3.6M | ★ 12.6M |
| Earning Date | 05-28-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 99.05 |
| EPS | ★ 0.27 | 0.03 |
| Revenue | $2,532,800,000.00 | ★ $6,054,525,000.00 |
| Revenue This Year | $6.66 | $15.47 |
| Revenue Next Year | $5.18 | $13.09 |
| P/E Ratio | ★ $261.30 | $770.83 |
| Revenue Growth | 18.41 | ★ 26.99 |
| 52 Week Low | $58.89 | $20.46 |
| 52 Week High | $89.83 | $48.78 |
| Indicator | COO | DKNG |
|---|---|---|
| Relative Strength Index (RSI) | 67.72 | 48.89 |
| Support Level | $67.91 | $24.18 |
| Resistance Level | $72.07 | $26.70 |
| Average True Range (ATR) | 1.84 | 1.52 |
| MACD | 0.48 | -0.44 |
| Stochastic Oscillator | 80.31 | 34.53 |
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
DraftKings got its start in 2012 as an innovator in daily fantasy sports. Then, following a Supreme Court ruling in 2018 that allowed states to legalize online sports wagering, the company expanded into online sports and casino gambling, where it generally holds the number-two or -three revenue share position across states where it competes. With its predictive market launch in 2025, DraftKings is now live with online or retail sports betting in most all states and i-gaming in five states, with both products available to around 40% of Canada's population. In 2025, sports revenue was 63% of total sales, i-gaming 30%, and fantasy and lottery 7%.